Pharmaceutical Equivalence of Film-Coated and Chewable Tablets: A Comparative Dissolution Study Using Pulverized Chewable Tablets

Overview

Journal Pharmaceuticals (Basel)

Publisher MDPI

Specialty Chemistry

Date 2024 Nov 27

PMID 39598435

Authors

Suck-Yong Park

Sung-Up Choi

Affiliations

Soon will be listed here.

Abstract

Famotidine is a histamine H2 receptor antagonist used in the treatment of gastrointestinal disorders. It is available in multiple formulations, including film-coated tablets, chewable tablets, oral suspension, and injections. The purpose of this study was to develop and evaluate the film-coated tablet (FT) containing famotidine, magnesium hydroxide, and precipitated calcium carbonate, designed to be pharmaceutically equivalent to the marketed chewable tablet (CT). To achieve the pharmaceutical equivalence of two tablets, the dissolution profiles of FT should be similar to those of CT. However, since CT is intended to be chewed before swallowing, testing it in its intact form would not provide accurate results. Therefore, pulverized chewable tablets (PCT) were used as the reference product. The dissolution, performed by the paddle method at 50 rpm, was analyzed by the validated UV method. Similarity factor () and difference factor () were calculated to assess the equivalence of the dissolution profiles. The results demonstrated that the dissolution profiles of the FT and CT were similar. Additionally, the acid-neutralizing capacity test confirmed the equivalence of the two antacids. This study is one of the first to propose that dissolution tests for pharmaceutical equivalence should be conducted on pulverized CTs when developing generic equivalents to CTs.

References

Zhu G, Wang L, Han S, Peng H, Tong M, Gu X . Pharmacokinetics and bioequivalence study of montelukast sodium oral soluble film and chewable tablet in healthy Chinese volunteers: randomized trials under fasting and fed conditions. Ann Transl Med. 2023; 11(2):93. PMC: 9929805. DOI: 10.21037/atm-22-6485. View

Usmani M, Shoaib M, Siddiqui F, Ahmed F, Yousuf R, Saleem M . Formulation development, in vivo bioequivalence and pediatric PBPK modeling studies of taste-masked ciprofloxacin chewable tablets. Sci Rep. 2023; 13(1):16070. PMC: 10522605. DOI: 10.1038/s41598-023-43423-0. View

Canovas M, Arcabell M, Martinez G, Canals M, Cabre F . Bioequivalence studies of film-coated tablet and chewable tablet generic formulations of montelukast in healthy volunteers. Arzneimittelforschung. 2012; 61(11):610-6. DOI: 10.1055/s-0031-1300563. View

Sawatdee S, Atipairin A, Sae Yoon A, Srichana T, Changsan N, Suwandecha T . Formulation Development of Albendazole-Loaded Self-Microemulsifying Chewable Tablets to Enhance Dissolution and Bioavailability. Pharmaceutics. 2019; 11(3). PMC: 6471907. DOI: 10.3390/pharmaceutics11030134. View

Chen Y, Feng T, Li Y, Du B, Weng W . Formulation and evaluation of a montelukast sodium orally disintegrating tablet with a similar dissolution profile as the marketed product. Pharm Dev Technol. 2015; 22(2):168-172. DOI: 10.3109/10837450.2015.1121498. View

Marcelin-Jimenez G, Angeles-Moreno A, Contreras-Zavala L, Garcia-Gonzalez A, Ramirez-San Juan E . Comparison of fasting bioavailability among 100-mg commercial, 100-mg generic, and 50-mg chewable generic sildenafil tablets in healthy male Mexican volunteers: a single-dose, 3-period, crossover study. Clin Ther. 2012; 34(3):689-98. DOI: 10.1016/j.clinthera.2012.01.021. View

Islam M, Narurkar M . Solubility, stability and ionization behaviour of famotidine. J Pharm Pharmacol. 1993; 45(8):682-6. DOI: 10.1111/j.2042-7158.1993.tb07088.x. View

Wesche D, Lutz S, Barnish G . Comparative study of chewable pyrantel pamoate: should standards for chewable tablets be revised?. P N G Med J. 1994; 37(1):12-4. View

Yang Y, Shah R, Yu L, Khan M . In vitro bioequivalence approach for a locally acting gastrointestinal drug: lanthanum carbonate. Mol Pharm. 2012; 10(2):544-50. DOI: 10.1021/mp300517p. View

10.

Krogstad P, Samson P, Acosta E, Moye J, Townley E, Bradford S . Pharmacokinetics and Safety of a Raltegravir-Containing Regimen in Children Aged 4 Weeks to 2 Years Living With Human Immunodeficiency Virus and Receiving Rifampin for Tuberculosis. J Pediatric Infect Dis Soc. 2020; 10(2):201-204. PMC: 7996637. DOI: 10.1093/jpids/piaa039. View

11.

Kimaro E, Tibalinda P, Shedafa R, Temu M, Kaale E . Formulation development of chewable albendazole tablets with improved dissolution rate. Heliyon. 2020; 5(12):e02911. PMC: 6931076. DOI: 10.1016/j.heliyon.2019.e02911. View

12.

Yoo H, Cho S, Choi Y, Lee H, Kwon J, Kim S . Comparison of pharmacokinetic characteristics of sildenafil citrate chewable tablets and film-coated tablets in healthy male subjects. Transl Clin Pharmacol. 2020; 25(3):153-156. PMC: 7033379. DOI: 10.12793/tcp.2017.25.3.153. View

13.

Knorr B, Hartford A, Li X, Yang A, Noonan G, Migoya E . Bioequivalence of the 4-mg Oral Granules and Chewable Tablet Formulations of Montelukast. Arch Drug Inf. 2010; 3(2):37-43. PMC: 2913109. DOI: 10.1111/j.1753-5174.2010.00029.x. View

14.

Shah V, Tsong Y, Sathe P, Liu J . In vitro dissolution profile comparison--statistics and analysis of the similarity factor, f2. Pharm Res. 1998; 15(6):889-96. DOI: 10.1023/a:1011976615750. View

15.

El-Gazayerly O, Rakkanka V, Ayres J . Novel chewable sustained-release tablet containing verapamil hydrochloride. Pharm Dev Technol. 2004; 9(2):181-8. DOI: 10.1081/pdt-120030248. View

16.

Zaid A, Abualhasan M, Watson D, Mousa A, Ghazal N, Bustami R . Investigation of the bioequivalence of montelukast chewable tablets after a single oral administration using a validated LC-MS/MS method. Drug Des Devel Ther. 2015; 9:5315-21. PMC: 4590312. DOI: 10.2147/DDDT.S87938. View